Patent details
EP4255397 Title: ORAL FORMULATIONS OF TENAPANOR
Basic Information
- Publication number:
- EP4255397
- PCT Application Number:
- US2021062069
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP218350874
- PCT Publication Number:
- WO2022120287
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ORAL FORMULATIONS OF TENAPANOR
- French Title of Invention:
- FORMULATIONS ORALES DE TÉNAPANOR
- German Title of Invention:
- ORALE FORMULIERUNGEN VON TENAPANOR
- SPC Number:
Dates
- Filing date:
- 06/12/2021
- Grant date:
- 18/02/2026
- EP Publication Date:
- 11/10/2023
- PCT Publication Date:
- 09/06/2022
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/02/2026
- EP B1 Publication Date:
- 18/02/2026
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 06/12/2041
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 11/02/2026
- Name:
- Ardelyx, Inc.
- Address:
- 34175 Ardenwood Blvd., Fremont, California 94555, United States (US)
- Name:
- AstraZeneca AB
- Address:
- Forskargatan 18, 151 85 Södertälje, Sweden (SE)
Inventor
1
- Name:
- GUNNARSSON, Cecilia
- Address:
- Sweden (SE)
2
- Name:
- MATIC, Hanna
- Address:
- Sweden (SE)
3
- Name:
- SALOMONSSON, John
- Address:
- Sweden (SE)
4
- Name:
- KARLSSON, Eva
- Address:
- Sweden (SE)
5
- Name:
- SWENSON, Magnus
- Address:
- Sweden (SE)
Priority
- Priority Number:
- 202063199078 P
- Priority Date:
- 04/12/2020
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/16; A61K 9/20; A61K 31/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202608
- Publication date:
- 18/02/2026
- Description:
- Grant (B1)
2
- Issue number:
- 202613
- Publication date:
- 25/03/2026
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 31/12/2026
- Annual Fee Number:
- 6
- Annual Fee Amount:
- 66 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|